10 results on '"Stati, V."'
Search Results
2. 104P Fast progression in high PD-L1 NSCLC treated with pembrolizumab in first-line: A prognostic scoring system based on clinical features
3. P2.04-49 Nivolumab Plus Ipilimumab (NI) Versus Chemotherapy Plus Nivolumab (CN) in Squamous Cell Lung Cancer (SqCLC): The SQUINT Trial
4. Nivolumab plus ipilimumab (NI) versus chemotherapy plus nivolumab (CN) in squamous cell lung cancer (SqCLC): The SQUINT trial
5. Correlation among different KRAS alterations, genetic co-mutations and PD-L1 expression in patients treated with immunotherapy in metastatic NSCLC
6. Immune-related adverse events correlate with clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with nivolumab in the Italian expanded access programme
7. Management of breakthrough cancer pain (BTcP) in patients with bone metastases of solid tumors
8. Oral Vinorelbine as single agent in the treatment of poor Performance Status (pPS) metastatic Non Small Cell Lung Cancer (NSCLC): a single institution experience
9. Primary prophylaxis of neutropenia in women affected by breast cancer undergoing adjuvant chemotherapy with fec 100 +/- docetaxel: comparison of efficacy and tolerability between lenograstim and pegfilgrastim
10. M372 INCIDENCE OF AMENORRHEA IN PREMENOPAUSAL WOMEN WITH BREAST CANCER (BC) UNDERGOING CHEMOTHERAPY (CT) WITH ANTHRACYCLINE (A), CYCLOPHOSPHAMIDE (C) AND DOCETAXEL (T)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.